FHAD1-AS1

Across TCGA pan-cancer cohorts, FHAD1-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated FHAD1-AS1 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher FHAD1-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FHAD1-AS1 expression acts as an unfavorable survival marker, although some lineages such as ACC and KIRC show a favorable association.

UVM, LGG, and ESCA are the cancer types where FHAD1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.075	0.835	<.001	81	view →
LGG	DFS	Tertile	All	0.597	0.771	<.001	35	view →
ESCA	OS	Tertile	II,III,IV	0.517	0.786	.004	34	view →
ACC	DFS	Median	IV	0.495	0.066	.001	23	view →
COAD	DFS	Tertile	IV	0.085	0.535	<.001	21	view →
KIRC	DFS	Tertile	III,IV	0.540	0.278	.027	20	view →
READ	OS	Tertile	II,III,IV	0.779	0.991	.015	20	view →
HNSC	OS	Tertile	All	0.190	0.474	.002	20	view →
MESO	OS	Tertile	IV	0.317	0.631	.032	18	view →
LUSC	OS	Quartile	III,IV	0.334	0.800	.017	18	view →
PAAD	OS	Tertile	II,III,IV	0.423	0.646	.010	13	view →
THCA	DFS	Tertile	All	0.871	0.766	.028	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

FHAD1-AS1–UVM (OS)

Open the UVM breakdown →